China NMPA Drug Inspection - Chongqing Jianfeng Pharmaceutical Co., Ltd. - talc

On June 24, 2020, the Chongqing Municipal Drug Administration released an announcement identifying nine batches of medical products from seven entities that failed to meet quality standards. The organizations involved include Sichuan Tongguo Pharmaceutical Printing and Packaging Co., Ltd., Chongqing Yirong Glass Products Co., Ltd., Chongqing Sanlitang Traditional Chinese Medicine Pharmaceutical Co., Ltd., Chongqing Traditional Chinese Medicine Slices Factory Co., Ltd., Chongqing Jianfeng Pharmaceutical Co., Ltd., and two healthcare facilities: Chongqing Fifth People's Hospital and Chongqing Tongliang District Traditional Chinese Medicine Hospital.

The violations involved several categories of products. Pharmaceutical packaging materials failed tests for water vapor transmission and heat resistance. Traditional Chinese Medicine (TCM) products showed deficiencies in physical properties, chemical reactions, and active ingredient content. Furthermore, hospital-prepared solutions were found non-compliant due to incorrect fill weights and excessive bacterial counts. These findings were based on quality standards set by the 2015 Chinese Pharmacopoeia, National Pharmaceutical Packaging Material Standards, and regional medical preparation guidelines.

In response to these findings, the Chongqing Municipal Drug Administration has mandated immediate regulatory actions. The involved bureaus must seize non-compliant inventory, suspend sales, and initiate product recalls. Additionally, formal investigations have been launched to handle the violations in accordance with national laws, ensuring that all manufacturers address the quality failures and maintain public safety.